Gender differences in cigarette smoking cessation attempts among adults who smoke and drink alcohol at high levels: Findings from the 2018-2020 International Tobacco Control Four Country Smoking and Vaping Surveys.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
12 2023
Historique:
received: 21 03 2023
revised: 16 07 2023
accepted: 27 07 2023
medline: 8 9 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

This study examined the association between alcohol consumption and smoking cessation behaviour of adults who smoke in four countries. Data came from 4275 adults (≥18 years) who smoked tobacco ≥ monthly and participated in the 2018 and 2020 International Tobacco Control Four Country Smoking and Vaping Surveys (Australia: n = 720; Canada: n = 1250; US: n = 1011; England: n = 1294). The 2018 Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) survey data coded into three levels ('never/low', 'moderate' or 'heavy' consumption) were analysed using multivariable logistic regression models to predict any smoking cessation attempts and successful cessation by 2020 survey, and whether this differed by gender and country. Compared to never/low alcohol consumers, only those who drink heavily were less likely to have made a quit smoking attempt (40.4 % vs. 43.8 %; AOR = 0.69, 95 % CI = 0.57-0.83, p < .001). The association differed by gender and country (3-way interaction, p < .001), with females who drink heavily being less likely to attempt to quit smoking in England (AOR = 0.27, 95 % CI = 0.15-0.49, p < .001) and Australia (AOR = 0.38, 95 % CI = 0.19-0.77, p = .008), but for males, those who drink moderately (AOR = 2.18, 95 % CI = 1.17-4.06, p = .014) or heavily (AOR = 2.61, 95 % CI = 1.45-4.68, p = .001) were more likely to make a quit attempt in England only. Alcohol consumption did not predict quit success. Heavy alcohol use among adults who smoke appears to only undermine the likelihood of trying to quit smoking with some variation by gender and country of residence, but not their chances of succeeding if they tried.

Sections du résumé

BACKGROUND
This study examined the association between alcohol consumption and smoking cessation behaviour of adults who smoke in four countries.
METHODS
Data came from 4275 adults (≥18 years) who smoked tobacco ≥ monthly and participated in the 2018 and 2020 International Tobacco Control Four Country Smoking and Vaping Surveys (Australia: n = 720; Canada: n = 1250; US: n = 1011; England: n = 1294). The 2018 Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) survey data coded into three levels ('never/low', 'moderate' or 'heavy' consumption) were analysed using multivariable logistic regression models to predict any smoking cessation attempts and successful cessation by 2020 survey, and whether this differed by gender and country.
RESULTS
Compared to never/low alcohol consumers, only those who drink heavily were less likely to have made a quit smoking attempt (40.4 % vs. 43.8 %; AOR = 0.69, 95 % CI = 0.57-0.83, p < .001). The association differed by gender and country (3-way interaction, p < .001), with females who drink heavily being less likely to attempt to quit smoking in England (AOR = 0.27, 95 % CI = 0.15-0.49, p < .001) and Australia (AOR = 0.38, 95 % CI = 0.19-0.77, p = .008), but for males, those who drink moderately (AOR = 2.18, 95 % CI = 1.17-4.06, p = .014) or heavily (AOR = 2.61, 95 % CI = 1.45-4.68, p = .001) were more likely to make a quit attempt in England only. Alcohol consumption did not predict quit success.
CONCLUSION
Heavy alcohol use among adults who smoke appears to only undermine the likelihood of trying to quit smoking with some variation by gender and country of residence, but not their chances of succeeding if they tried.

Identifiants

pubmed: 37536221
pii: S0306-4603(23)00212-5
doi: 10.1016/j.addbeh.2023.107817
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107817

Subventions

Organisme : NCI NIH HHS
ID : P01 CA200512
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: GTF has served as an expert witness/consultant for governments defending their country’s policies/regulations in litigation. KMC has served as a paid expert witness in litigation filed against cigarette manufacturers. CG has performed consultancy work for HMA consultants on behalf of the Australian Government and contract research for World Health Organization. All other authors declare no conflict of interest.

Auteurs

Chenyang Liu (C)

School of Psychology, Deakin University, Geelong, Victoria, Australia. Electronic address: cliu26@myune.edu.au.

Hua-Hie Yong (HH)

School of Psychology, Deakin University, Geelong, Victoria, Australia. Electronic address: hua.yong@deakin.edu.au.

Shannon Gravely (S)

Department of Psychology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada. Electronic address: shannon.gravely@uwaterloo.ca.

Katherine East (K)

National Addiction Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK. Electronic address: katherine.east@kcl.ac.uk.

Karin Kasza (K)

Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Electronic address: karin.kasza@RoswellPark.org.

Coral Gartner (C)

School of Public Health, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: c.gartner@uq.edu.au.

K Michael Cummings (KM)

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: cummingk@musc.edu.

Geoffrey T Fong (GT)

Department of Psychology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada; School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada; Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada. Electronic address: geoffrey.fong@uwaterloo.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH